Lucira Health, Inc.
LHDX · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $299,357 | $895,963 | $384,730 | $384,730 |
| - Cash | $105,982 | $58,212 | $4,100 | $97 |
| + Debt | $2,829 | $25,505 | $1,110 | $4,260 |
| Enterprise Value | $196,204 | $863,256 | $381,740 | $388,893 |
| Revenue | $93,055 | $269 | $0 | $0 |
| % Growth | 34,492.9% | – | – | – |
| Gross Profit | $10,224 | -$1,672 | $0 | $0 |
| % Margin | 11% | -621.6% | – | – |
| EBITDA | -$60,525 | -$29,500 | -$7,420 | -$5,914 |
| % Margin | -65% | -10,966.5% | – | – |
| Net Income | -$64,827 | -$37,401 | -$8,557 | -$6,726 |
| % Margin | -69.7% | -13,903.7% | – | – |
| EPS Diluted | -1.86 | -1.04 | -0.56 | -0.44 |
| % Growth | -78.8% | -85.7% | -27.3% | – |
| Operating Cash Flow | -$100,878 | -$32,524 | -$7,062 | -$6,465 |
| Capital Expenditures | -$15,391 | -$18,812 | -$75 | -$146 |
| Free Cash Flow | -$116,269 | -$51,336 | -$7,137 | -$6,611 |